HuGE Literature Finder
Records
1
-
18
| Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer. European urology 2022 Aug . Gil-Jimenez Alberto, van Dorp Jeroen, Contreras-Sanz Alberto, van der Vos Kristan, Vis Daniel J, Braaf Linde, Broeks Annegien, Kerkhoven Ron, van Kessel Kim E M, Ribal María José, Alcaraz Antonio, Wessels Lodewyk F A, Seiler Roland, Wright Jonathan L, Mengual Lourdes, Boormans Joost, van Rhijn Bas W G, Black Peter C, van der Heijden Michiel |
| Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non-Muscle-Invasive Bladder Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Jul . Pietzak Eugene J, Whiting Karissa, Srinivasan Preethi, Bandlamudi Chaitanya, Khurram Aliya, Joseph Vijai, Walasek Aleksandra, Bochner Emily, Clinton Timothy, Almassi Nima, Truong Hong, de Jesus Escano Manuel R, Wiseman Michal, Mandelker Diana, Kemel Yelena, Zhang Liying, Walsh Michael F, Cadoo Karen A, Coleman Jonathan A, Al-Ahmadie Hikmat, Rosenberg Jonathan E, Iyer Gopakumar V, Solit David B, Ostrovnaya Irina, Offit Kenneth, Robson Mark E, Stadler Zsofia K, Berger Michael F, Bajorin Dean F, Carlo Maria, Bochner Bernard |
| The association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer. Journal of thoracic disease 2021 6 13 (5): 3126-3136. Jiang Chenxue, Guo Yanling, Li Yefei, Kang Jingjing, Sun Xiaojiang, Wu Hongyu, Feng Jianguo, Xu Yapi |
| The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population. Pharmacogenomics and personalized medicine 2021 14 359-367. Wei Zhengbo, Yao Mengwei, Ning Sisi, Wu Yuan, Zhou Xunzhao, Zhong Changtao, Yan Kui, Xie Yi |
| Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancer. Scientific reports 2020 10 10 (1): 16641. Le Goux Constance, Vacher Sophie, Schnitzler Anne, Barry Delongchamps Nicolas, Zerbib Marc, Peyromaure Michael, Sibony Mathilde, Allory Yves, Bieche Ivan, Damotte Diane, Pignot Geraldi |
| ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy. The pharmacogenomics journal 2020 6 21 (1): 37-46. Guberina Maja, Sak Ali, Pöttgen Christoph, Tinhofer-Keilholz Ingeborg, Budach Volker, Balermpas Panagiotis, Von der Grün Jens, Rödel Claus Michael, Gkika Eleni, Grosu Anca-Ligia, Abdollahi Amir, Debus Jürgen, Belka Claus, Pigorsch Steffi, Combs Stephani E, Mönnich David, Zips Daniel, De-Colle Chiara, Welz Stefan, Linge Annett, Lohaus Fabian, Baretton Gustavo, Gauler Thomas, Baumann Michael, Krause Mechthild, Schuler Martin, Bankfalvi Agnes, Höing Benedikt, Lang Stephan, Stuschke Mart |
| Genomic Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer. Cancer research 2020 9 80 (20): 4476-4486. Bellmunt Joaquim, Kim Jaegil, Reardon Brendan, Perera-Bel Júlia, Orsola Anna, Rodriguez-Vida Alejo, Wankowicz Stephanie A, Bowden Michaela, Barletta Justine A, Morote Juan, de Torres Inés, Juanpere Nuria, Lloreta-Trull Josep, Hernandez Silvia, Mouw Kent W, Taplin Mary-Ellen, Cejas Paloma, Long Henry W, Van Allen Eliezer M, Getz Gad, Kwiatkowski David |
| Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification. BJU international 2019 May . Ward Douglas G, Gordon Naheema S, Boucher Rebecca H, Pirrie Sarah J, Baxter Laura, Ott Sascha, Silcock Lee, Whalley Celina M, Stockton Joanne D, Beggs Andrew D, Griffiths Mike, Abbotts Ben, Ijakipour Hanieh, Latheef Fathimath N, Robinson Robert A, White Andrew J, James Nicholas D, Zeegers Maurice P, Cheng K K, Bryan Richard |
| Genomic Differences Between "Primary" and "Secondary" Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy. European urology 2018 10 75 (2): 231-239. Pietzak Eugene J, Zabor Emily C, Bagrodia Aditya, Armenia Joshua, Hu Wenhuo, Zehir Ahmet, Funt Samuel, Audenet Francois, Barron David, Maamouri Noelia, Li Qiang, Teo Min Yuen, Arcila Maria E, Berger Michael F, Schultz Nikolaus, Dalbagni Guido, Herr Harry W, Bajorin Dean F, Rosenberg Jonathan E, Al-Ahmadie Hikmat, Bochner Bernard H, Solit David B, Iyer Go |
| Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer. Oncotarget 2017 Feb . Zanusso Chiara, Bortolus Roberto, Dreussi Eva, Polesel Jerry, Montico Marcella, Cecchin Erika, Gagno Sara, Rizzolio Flavio, Arcicasa Mauro, Novara Giacomo, Toffoli Giusep |
| Genomic characterization of response to chemoradiation in urothelial bladder cancer. Cancer 2016 Aug . Desai Neil B, Scott Sasinya N, Zabor Emily C, Cha Eugene K, Hreiki Joseph, Sfakianos John P, Ramirez Ricardo, Bagrodia Aditya, Rosenberg Jonathan E, Bajorin Dean F, Berger Michael F, Bochner Bernard H, Zelefsky Michael J, Kollmeier Marisa A, Ostrovnaya Irina, Al-Ahmadie Hikmat A, Solit David B, Iyer Go |
| A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Apr 26 (4): 624-44. Findlay J M, Middleton M R, Tomlinson |
| Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations of UNC5C and prognostic importance of DNA repair gene mutations on survival. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Dec 20 (24): 6605-17. Yap Kai Lee, Kiyotani Kazuma, Tamura Kenji, Antic Tatjana, Jang Miran, Montoya Magdeline, Campanile Alexa, Yew Poh Yin, Ganshert Cory, Fujioka Tomoaki, Steinberg Gary D, O'Donnell Peter H, Nakamura Yusu |
| Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2013 May 22 (5): 987-92. White Kristin L, Vierkant Robert A, Fogarty Zachary C, Charbonneau Bridget, Block Matthew S, Pharoah Paul D P, Chenevix-Trench Georgia, , Rossing Mary Anne, Cramer Daniel W, Pearce Celeste Leigh, Schildkraut Joellen M, Menon Usha, Kjaer Susanne Kruger, Levine Douglas A, Gronwald Jacek, Culver Hoda Anton, Whittemore Alice S, Karlan Beth Y, Lambrechts Diether, Wentzensen Nicolas, Kupryjanczyk Jolanta, Chang-Claude Jenny, Bandera Elisa V, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Fasching Peter A, Campbell Ian, Goodman Marc T, Pejovic Tanja, Bean Yukie, Lurie Galina, Eccles Diana, Hein Alexander, Beckmann Matthias W, Ekici Arif B, Paul James, Brown Robert, Flanagan James M, Harter Philipp, du Bois Andreas, Schwaab Ira, Hogdall Claus K, Lundvall Lene, Olson Sara H, Orlow Irene, Paddock Lisa E, Rudolph Anja, Eilber Ursula, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Ziolkowska-Seta Izabela, Brinton Louise, Yang Hannah, Garcia-Closas Montserrat, Despierre Evelyn, Lambrechts Sandrina, Vergote Ignace, Walsh Christine, Lester Jenny, Sieh Weiva, McGuire Valerie, Rothstein Joseph H, Ziogas Argyrios, Lubinski Jan, Cybulski Cezary, Menkiszak Janusz, Jensen Allan, Gayther Simon A, Ramus Susan J, Gentry-Maharaj Aleksandra, Berchuck Andrew, Wu Anna H, Pike Malcolm C, Van Denberg David, Terry Kathryn L, Vitonis Allison F, Doherty Jennifer A, Johnatty Sharon E, Defazio Anna, Song Honglin, Tyrer Jonathan, Sellers Thomas A, Phelan Catherine M, Kalli Kimberly R, Cunningham Julie M, Fridley Brooke L, Goode Ellen |
| Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Nov 20 (11): 2429-37. Zhong Shilong, Nukui Tomoko, Buch Shama, Diergaarde Brenda, Weissfeld Lisa A, Grandis Jennifer, Romkes Marjorie, Weissfeld Joel |
| Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International journal of molecular epidemiology and genetics 2011 2 (2): 185-95. Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen |
| Impact of nucleotide excision repair ERCC2 and base excision repair APEX1 genes polymorphism and its association with recurrence after adjuvant BCG immunotherapy in bladder cancer patients of North India. Medical oncology (Northwood, London, England) 2010 Jun 27 (2): 159-66. Gangawar Ruchika, Ahirwar Dinesh, Mandhani Anil, Mittal Rama De |
| Independent Replication of Published Germline Polymorphisms Associated with Urinary Bladder Cancer Prognosis and Treatment Response. Bladder cancer 0 2 (1): 77-89. Grotenhuis Anne J, Dudek Aleksandra M, Verhaegh Gerald W, Aben Katja K, Witjes J Alfred, Kiemeney Lambertus A, Vermeulen Sita |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: